Trials / Recruiting
RecruitingNCT05535894
Endoscopic Radiofrequency Ablation of Celiac Ganglion for Pain Management and Improvement of Quality of Life in Patients With Unresectable Pancreatic Cancer
Endoscopic Ultrasound-guided Radiofrequency Ablation of Celiac Ganglion for Pain Management and Improvement of Quality of Life in Patients With Unresectable Pancreatic Cancer
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 12 (estimated)
- Sponsor
- West Virginia University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the EUS-RFA in terms of efficacy for pain management and improvement in quality-of-life parameters for patients with advanced inoperable pancreatic cancer. The primary objectives of this study are to 1) evaluate the utility of EUS-RFA for pain control and improvement in quality-of-life parameters for patients with advanced pancreatic cancer; 2) to measure the reduction of analgesic medications' requirements in patients affected by inoperable pancreatic cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Ablation of Celiac Ganglion | Endoscopic Ultrasound-guided Radiofrequency Ablation of Celiac Ganglion |
Timeline
- Start date
- 2022-08-10
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2022-09-10
- Last updated
- 2025-03-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05535894. Inclusion in this directory is not an endorsement.